Estimation of the Level of Interlukien-33 and Tumour Necrosis Factor-α in Lesional Tissues of Patients with Vitiligo
El-Rifaie, A., Rashed, L., Abd Allah, A., El-Ashry, E. (2020). Estimation of the Level of Interlukien-33 and Tumour Necrosis Factor-α in Lesional Tissues of Patients with Vitiligo. EKB Journal Management System, 31(2), 293-302. doi: 10.21608/mjmr.2022.221077
Abd E. El-Rifaie; Laila A. Rashed; Ahlam H. Abd Allah; El-Shaimaa S. A. El-Ashry. "Estimation of the Level of Interlukien-33 and Tumour Necrosis Factor-α in Lesional Tissues of Patients with Vitiligo". EKB Journal Management System, 31, 2, 2020, 293-302. doi: 10.21608/mjmr.2022.221077
El-Rifaie, A., Rashed, L., Abd Allah, A., El-Ashry, E. (2020). 'Estimation of the Level of Interlukien-33 and Tumour Necrosis Factor-α in Lesional Tissues of Patients with Vitiligo', EKB Journal Management System, 31(2), pp. 293-302. doi: 10.21608/mjmr.2022.221077
El-Rifaie, A., Rashed, L., Abd Allah, A., El-Ashry, E. Estimation of the Level of Interlukien-33 and Tumour Necrosis Factor-α in Lesional Tissues of Patients with Vitiligo. EKB Journal Management System, 2020; 31(2): 293-302. doi: 10.21608/mjmr.2022.221077

Estimation of the Level of Interlukien-33 and Tumour Necrosis Factor-α in Lesional Tissues of Patients with Vitiligo

Minia Journal of Medical Research
Volume 31, Issue 2, April 2020, Page 293-302  XML PDF (454.89 K)
Document Type: Original Article
DOI: 10.21608/mjmr.2022.221077
View on SCiNiTO View on SCiNiTO
Authors
Abd E. El-Rifaie1; Laila A. Rashed2; Ahlam H. Abd Allah1; El-Shaimaa S. A. El-Ashry1
1Department of Dermatology, Faculty of Medicine, Beni-Suef University, Egypt
2Department of Biochemistry, Faculty of Medicine, Cairo University, Egypt
Abstract
Background: Vitiligo is a common acquired immune disorder of the skin characterized by the presence of 
milky white depigmented macules in various distributions. It is an autoimmune disorder caused by the 
destruction of melanocytes in the skin. Its immunopathogenesis is not fully understood, but there are 
inflammatory alterations in the skin microenvironment. Aim of the work: This study aims to estimate 
the level of IL-33 and TNF–alpha in lesional tissues of patients with vitiligo in comparison with 
healthy controls. Subjects and methods: this is a case control study that was conducted on outpatients attending Beni-Suef University Hospital, 30 patients with vitiligo and 30 healthy 
controls, Tissue samples was be collected by punch biopsy (4mm) in diameter from Lesion 
(vitiliginous areas) of the patients and normal skin from the healthy controls. Results: TNF-α 
and IL-33 tissue levels were significantly increaesd in patients with vitiligo compared with healthy 
controls. No correlation between Level of Interlukien-33 and level of Tumor Necrosis Factor-α in 
Vitiligo Lesions among Studied Cases; (p-values> 0.05). Conclusion: Tissue IL-33 levels in 
patients with vitiligo were significantly increased compared with healthy controls. IL-33 could be 
considered a reliable marker for the disease. These results also might partly explain the mechanism 
for TNF-α inhibitor efficacy in patients with vitiligo. Tumour necrosis factor (TNF)‐α, a 
proinflammatory cytokine central to many autoimmune diseases, has been implicated in the 
depigmentation process in vitiligo, as it is also increased in patients with vitiligo compared with 
healthy controls.

Keywords
Vitiligo; IL-33; TNF–alpha; case control
Supplementary Files
Statistics
Article View: 56
PDF Download: 174